David Geffen School of Medicine at UCLA
Los Angeles, Ca
Dvid Geffen School of Medicine at UCLA
Los Angeles, Ca
UC Irvine School Of Medicine
Certified in Diagnostic Radiology
Dr. Azita Behrashi
Azita Behrashi, M.D., is a board certified radiologist with sub-specialty in breast imaging and has been part of the Breastlink team since 2008. She is certified by the American Board of Radiology, and received postgraduate fellowship training in breast and thoracic imaging at UCLA from 2003 to 2007. She also completed an MRI fellowship at University of California, Irvine in 2002. Prior to joining Breastlink at Orange, she served as the Medical Director of the Women’s Imaging at Orange County Diagnostics.
Dr Azita Behrashi taught and worked with radiology residents and breast imaging fellows as a voluntary faculty member at the Iris Cantor Breast center at UCLA from 2007 to 2012.
Dr. Behrashi is a member of the American College of Radiology as well as the Radiologic Society of North America. She has specialized in interpreting all the breast imaging modalities including digital mammographies, 3D mammographies, breast ultrasounds and breast MRIs. Dr. Behrashi also performs imaging guided breast biopsies, including MRI guided breast biopsies, ultrasounds and stereotactic guided breast biopsies, as well as preoperative needle localizations for the patients who have been diagnosed with breast cancer and desire a lumpectomy.
Her excellent work and dedication to her professional mission of early breast cancer detection has been recognized by her patients and community. In 2016, she received the Physician Excellence of Orange County Award.
When asked what she loves about her specialty, Dr. Behrashi said “I am a strong believer that mammography saves lives. Most of us have been touched in some way by breast cancer. The most rewarding part of my job is to diagnose breast cancer at its earliest and most treatable stage.”
Dr Behrashi believes working with a team of dedicated breast surgeons and oncologists at Breastlink will help breast cancer patients better understand their treatment options and choose the best treatment available to them.